Seroquel SR FDA Approval Nov, 2007

[Retired]

Seroquel XR Receives Approval From FDA for Maintenance Treatment of Schizophrenia

Seroquel XR (quetiapine fumarate) Extended-Release Tablets

New Indication Approved: November 15, 2007
Treatment for: Maintenance Treatment of Schizophrenia

Seroquel XR is an atypical antipsychotic drug formulated for once-daily dosing. Seroquel XR was first approved in May 2007 for the acute treatment of schizophrenia in adult patients. Seroquel XR is now also approved for the maintenance treatment of schizophrenia in adult patients.

Schizophrenia patients experience high rates of symptom relapse, and as a result, there is an important need for long-term treatment options for schizophrenia to help reduce the risk of the recurrence of acute psychotic episodes

Complete Press Release